Coya Therapeutics, Inc. (COYA) vs Outlook Therapeutics, Inc. (OTLK)
A side-by-side comparison of Coya Therapeutics, Inc. and Outlook Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
COYA
Coya Therapeutics, Inc.
$4.98HealthcareDelayed quote: Oct 6, 2026, 12:24 PM EDT
OTLK
Outlook Therapeutics, Inc.
$0.58HealthcareDelayed quote: Oct 6, 2026, 12:20 PM EDT
Total return — COYA vs OTLK
growth of $100 · dividends reinvested · last 4yCOYA +6.1% (+1.5%/yr)OTLK -97.1% (-58.6%/yr)COYA compounded faster over this window
Log scale — wide-divergence pair
COYA OTLK
COYA vs OTLK: by the numbers
- •COYA is the larger company ($117M vs $109M market cap).
- •Both run net losses; COYA's is the smaller (-270.22% vs -4416.22% net margin).
Metrics side by side
Valuation
| Metric | COYA | OTLK |
|---|---|---|
| P/S ratio | 14.57 | N/A |
| P/B ratio | 0.00 | N/A |
Profitability
| Metric | COYA | OTLK |
|---|---|---|
| Gross margin | 99.91% | 46.49% |
| Operating margin | -255.05% | -4744.25% |
| Net margin | -270.22% | -4416.22% |
| ROE | -0.05% | N/A |
| ROIC | -0.05% | -352.19% |
Growth (annualized)
| Metric | COYA | OTLK |
|---|---|---|
| Total return CAGR (5Y) | N/A | -57.40% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.